Position in ABBV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$89,964,953
+$15,915,003 QoQ
Shares Held
413,651
+27.6% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LGT Group Foundation holds $1,040,407,974 across 8 Drug Manufacturers - General names. ABBV ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,890,121 | $372,769,659 | |
| 2 | LLY |
ELI LILLY & Co
|
399,693 | $367,625,628 | |
| 3 | JNJ |
Johnson & Johnson
|
497,989 | $121,728,428 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
413,651 | $89,964,953 | |
| 5 | PFE |
Pfizer Inc
|
2,206,233 | $61,951,021 | |
| 6 | MRK |
Merck & Co., Inc.
|
194,925 | $23,447,526 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
19,824 | $1,202,324 |
All Filings in ABBV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $89,964,953 | 413,651 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $74,049,950 | 324,084 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $73,943,684 | 319,356 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $45,241,901 | 243,734 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $48,048,171 | 229,325 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $26,069,654 | 146,706 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $26,701,862 | 135,213 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,799,468 | 80,454 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $1,879,635 | 10,322 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,900,704 | 12,265 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $2,228,892 | 14,953 | Shares | Defined | 2023-11-06 | |
| 2023-06-30 | $1,784,361 | 13,244 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $1,983,994 | 12,449 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $2,397,160 | 14,833 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $3,698,826 | 27,560 | Shares | Defined | 2022-10-19 | |
| 2022-06-30 | $4,571,671 | 29,849 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $5,145,045 | 31,738 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $9,043,906 | 66,794 | Shares | Defined | 2022-05-03 | |
| No filing history on record for this holder in this stock. | ||||||